The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum

Drug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 rece...

Full description

Bibliographic Details
Main Authors: Anna M. Klawonn, Anna Nilsson, Carl F. Rådberg, Sarah H. Lindström, Mia Ericson, Björn Granseth, David Engblom, Michael Fritz
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/full
id doaj-b7791248436c46198c2019d444536370
record_format Article
spelling doaj-b7791248436c46198c2019d4445363702020-11-24T22:44:26ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122017-10-01810.3389/fphar.2017.00714305488The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the StriatumAnna M. Klawonn0Anna Nilsson1Carl F. Rådberg2Sarah H. Lindström3Mia Ericson4Björn Granseth5David Engblom6Michael Fritz7Cell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenAddiction Biology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Gothenburg, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenCell Biology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, SwedenDrug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 receptors have been meticulously studied in psychostimulant reinforced Pavlovian learning, while the sigma-2 receptor subtype has remained unexplored. Recent development of selective sigma-2 receptor ligands have now made it possible to investigate if the sigma-2 receptor system is a potential target to treat drug addiction. We examined the effect of the sigma-2 receptor agonist Siramesine (Lu 28-179) on cocaine-associated locomotion, Pavlovian learning, and reward neurocircuitry using electrophysiology recordings and in vivo microdialysis. We found that Siramesine significantly attenuated conditioned place preference acquisition and expression, as well as it completely blocked cocaine-primed reinstatement. Siramesine, in a similar manner as the selective sigma-1 receptor antagonist BD 1063, decreased acute locomotor responses to cocaine. Immunohistochemistry suggests co-expression of progesterone receptor membrane component 1/sigma-2 receptors and vesicular glutamate transporter 1 in presynaptic boutons of the nucleus accumbens (NAc). Whole-cell voltage clamp recordings of neurons in the NAc indicated that Siramesine decreases the presynaptic release probability of glutamate. Further, we demonstrated, via in vivo microdialysis, that Siramesine significantly decreased cocaine-evoked dopamine release in the striatum of freely moving mice. Collectively, these findings demonstrate that sigma-2 receptors regulate neurocircuitry responsible for positive reinforcement and thereby play a role in cocaine-reinforced Pavlovian behaviors.http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/fulladdictioncocaineconditioned place preferencesigma-receptorSiramesineelectrophysiology
collection DOAJ
language English
format Article
sources DOAJ
author Anna M. Klawonn
Anna Nilsson
Carl F. Rådberg
Sarah H. Lindström
Mia Ericson
Björn Granseth
David Engblom
Michael Fritz
spellingShingle Anna M. Klawonn
Anna Nilsson
Carl F. Rådberg
Sarah H. Lindström
Mia Ericson
Björn Granseth
David Engblom
Michael Fritz
The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
Frontiers in Pharmacology
addiction
cocaine
conditioned place preference
sigma-receptor
Siramesine
electrophysiology
author_facet Anna M. Klawonn
Anna Nilsson
Carl F. Rådberg
Sarah H. Lindström
Mia Ericson
Björn Granseth
David Engblom
Michael Fritz
author_sort Anna M. Klawonn
title The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
title_short The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
title_full The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
title_fullStr The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
title_full_unstemmed The Sigma-2 Receptor Selective Agonist Siramesine (Lu 28-179) Decreases Cocaine-Reinforced Pavlovian Learning and Alters Glutamatergic and Dopaminergic Input to the Striatum
title_sort sigma-2 receptor selective agonist siramesine (lu 28-179) decreases cocaine-reinforced pavlovian learning and alters glutamatergic and dopaminergic input to the striatum
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2017-10-01
description Drug addiction is a chronic, debilitating disease that affects millions of people around the world causing a substantial societal burden. Despite decades of research efforts, treatment possibilities remain limited and relapse represents the most treatment-resistant element. Neurosteroid sigma-1 receptors have been meticulously studied in psychostimulant reinforced Pavlovian learning, while the sigma-2 receptor subtype has remained unexplored. Recent development of selective sigma-2 receptor ligands have now made it possible to investigate if the sigma-2 receptor system is a potential target to treat drug addiction. We examined the effect of the sigma-2 receptor agonist Siramesine (Lu 28-179) on cocaine-associated locomotion, Pavlovian learning, and reward neurocircuitry using electrophysiology recordings and in vivo microdialysis. We found that Siramesine significantly attenuated conditioned place preference acquisition and expression, as well as it completely blocked cocaine-primed reinstatement. Siramesine, in a similar manner as the selective sigma-1 receptor antagonist BD 1063, decreased acute locomotor responses to cocaine. Immunohistochemistry suggests co-expression of progesterone receptor membrane component 1/sigma-2 receptors and vesicular glutamate transporter 1 in presynaptic boutons of the nucleus accumbens (NAc). Whole-cell voltage clamp recordings of neurons in the NAc indicated that Siramesine decreases the presynaptic release probability of glutamate. Further, we demonstrated, via in vivo microdialysis, that Siramesine significantly decreased cocaine-evoked dopamine release in the striatum of freely moving mice. Collectively, these findings demonstrate that sigma-2 receptors regulate neurocircuitry responsible for positive reinforcement and thereby play a role in cocaine-reinforced Pavlovian behaviors.
topic addiction
cocaine
conditioned place preference
sigma-receptor
Siramesine
electrophysiology
url http://journal.frontiersin.org/article/10.3389/fphar.2017.00714/full
work_keys_str_mv AT annamklawonn thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT annanilsson thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT carlfradberg thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT sarahhlindstrom thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT miaericson thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT bjorngranseth thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT davidengblom thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT michaelfritz thesigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT annamklawonn sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT annanilsson sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT carlfradberg sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT sarahhlindstrom sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT miaericson sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT bjorngranseth sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT davidengblom sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
AT michaelfritz sigma2receptorselectiveagonistsiramesinelu28179decreasescocainereinforcedpavlovianlearningandaltersglutamatergicanddopaminergicinputtothestriatum
_version_ 1725691784905883648